Considering our findings that highlight the significant role of γ-H2AX in patients with pancreatic ductal adenocarcinoma (PDAC), future research should explore the potential of γ-H2AX as a non-invasive biomarker in peripheral blood. The gene discussed is H2AX; the disease is pancreatic ductal adenocarcinoma.